stockrowGinkgo Bioworks Holdings, Inc. (DNA) vs OmniAb, Inc. (OABI)
- Ginkgo Bioworks Holdings, Inc. DNA 11.19 +12.35%
- OmniAb, Inc. OABI 5.02 +3.93%
Ginkgo Bioworks Holdings, Inc. and OmniAb, Inc. are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and OmniAb, Inc. are of similar size ($704.5M and $670.7M). OmniAb, Inc. grew revenue faster over the last twelve months: 90.6% against −51.5%. OmniAb, Inc. has the higher net margin (−108.1% vs −260.0%) and the higher return on invested capital (−15.8% vs −161.9%). Across the 16 metrics below, OmniAb, Inc. leads on 11 and Ginkgo Bioworks Holdings, Inc. on 5.
Valuation
Profitability
| Metric | DNA | OABI | Biotechnology median |
|---|---|---|---|
| Gross margin | 80.55% | 97.65% | 68.51% |
| Operating margin | (273.61%) | (115.89%) | 0.00% |
| Net margin | (259.96%) | (108.11%) | 0.00% |
| Free cash flow margin | (155.75%) | 5.92% | 0.00% |
| Return on equity | (56.29%) | (16.51%) | (51.96%) |
| Return on assets | (26.19%) | (14.48%) | (46.06%) |
| Return on invested capital | (161.94%) | (15.75%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack